Thursday, 23 July 2020

Glenmark's Favipiravir shows positive results in Phase-3 clinical trials

Pharmaceutical giant Glenmark on Wednesday said its Phase-3 clinical trials of antiviral drug Favipiravir showed improvement in mild and moderate novel coronavirus patients. In a statement on Wednesday, Glemnmark said Covid-19 patients administered with Favipiravir reported faster clinical cure and viral clearance as compared to those with routine care.


No comments:

Featured Post

Did humpty dumpty really have a great fall ?

The Hindenburg report, released on 24th Jan, 2023 had the intended outcome. The short seller shaved off $ 100 Billion Dollars or more of Ada...